Antagonis reseptor (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antagonis reseptor" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

25doi.org

2^nd place

4^th place

24nih.gov

4^th place

13^th place

14worldcat.org

5^th place

7^th place

2intechopen.com

low place

5,116^th place

2oup.com

485^th place

563^rd place

2researchgate.net

120^th place

59^th place

1etymonline.com

287^th place

137^th place

1oxfordlearnersdictionaries.com

3,593^rd place

1,944^th place

1msdmanuals.com

4,047^th place

low place

1psu.edu

207^th place

525^th place

1nature.com

234^th place

238^th place

1sagepub.com

731^st place

844^th place

1elsevier.com

610^th place

597^th place

1guidetopharmacology.org

low place

1merckmanuals.com

3,097^th place

2,430^th place

1derangedphysiology.com

low place

derangedphysiology.com

"Competitive and non-competitive antagonists | Deranged Physiology". derangedphysiology.com (dalam bahasa Inggris). Diakses tanggal 2022-02-25.

doi.org

Christopoulos, Arthur (2002-03). "Allosteric binding sites on cell-surface receptors: novel targets for drug discovery". Nature Reviews Drug Discovery (dalam bahasa Inggris). 1 (3): 198–210.p1. doi:10.1038/nrd746. ISSN 1474-1776.
Reyes-Alcaraz, Arfaxad; Y. Lucero Garcia-Rojas, Emilio; A. Bond, Richard; K. McConnell, Bradley (2020-12-16). Catala, Angel; Ahmad, Usama, ed. Allosteric Modulators for GPCRs as a Therapeutic Alternative with High Potential in Drug Discovery (dalam bahasa Inggris). IntechOpen. doi:10.5772/intechopen.91838. ISBN 978-1-83962-931-0.
Negus SS (Juni 2006). "Some implications of receptor theory for in vivo assessment of agonists, antagonists and inverse agonists". Biochemical Pharmacology. 71 (12): 1663–70. doi:10.1016/j.bcp.2005.12.038. PMC 1866283 . PMID 16460689.
Ariëns, E J; Simonis, A M (2011-04-12). "A molecular basis for drug action.: The interaction of one or more drugs with different receptors". Journal of Pharmacy and Pharmacology (dalam bahasa Inggris). 16 (5): 289–312. doi:10.1111/j.2042-7158.1964.tb07461.x. ISSN 2042-7158.
Stephenson RP (February 1997). "A modification of receptor theory. 1956". British Journal of Pharmacology. 120 (4 Suppl): 106–20; discussion 103–5. doi:10.1111/j.1476-5381.1997.tb06784.x. PMC 3224279 . PMID 9142399. of the original article.
Vauquelin, G.; Van Liefde, I. (2005-02). "G protein-coupled receptors: a count of 1001 conformations". Fundamental & Clinical Pharmacology. 19 (1): 45–56. doi:10.1111/j.1472-8206.2005.00319.x. ISSN 0767-3981. PMID 15660959.
Chang, Steven D; Bruchas, Michael R (2014-01). "Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery". Neuropsychopharmacology (dalam bahasa Inggris). 39 (1): 248–249. doi:10.1038/npp.2013.205. ISSN 0893-133X. PMC 3857652 . PMID 24317323. Pemeliharaan CS1: Format PMC (link)
Berg, Kelly A; Clarke, William P (2018-10-01). "Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity". International Journal of Neuropsychopharmacology (dalam bahasa Inggris). 21 (10): 962–977. doi:10.1093/ijnp/pyy071. ISSN 1461-1457. PMC 6165953 . PMID 30085126. Pemeliharaan CS1: Format PMC (link)
Magoma, Gabriel (2013-01-23). El-Shemy, Hany, ed. Introduction to Biochemical Pharmacology and Drug Discovery (dalam bahasa Inggris). InTech. doi:10.5772/52014. ISBN 978-953-51-0906-8.
Wyllie DJ, Chen PE (March 2007). "Taking the time to study competitive antagonism". British Journal of Pharmacology. 150 (5): 541–51. doi:10.1038/sj.bjp.0706997. PMC 2189774 . PMID 17245371.
Colquhoun, David (2007-12). "Why the Schild method is better than Schild realised". Trends in Pharmacological Sciences (dalam bahasa Inggris). 28 (12): 608–614. doi:10.1016/j.tips.2007.09.011.
Schild HO (February 1975). "An ambiguity in receptor theory". British Journal of Pharmacology. 53 (2): 311. doi:10.1111/j.1476-5381.1975.tb07365.x. PMC 1666289 . PMID 1148491.
Buker, Shane M.; Boriack-Sjodin, P. Ann; Copeland, Robert A. (2019-06). "Enzyme–Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality". SLAS DISCOVERY: Advancing the Science of Drug Discovery (dalam bahasa Inggris). 24 (5): 515–522. doi:10.1177/2472555219829898. ISSN 2472-5552.
Wyllie, D. J. A.; Chen, P. E. (2007-03). "Taking the time to study competitive antagonism". British Journal of Pharmacology. 150 (5): 541–551. doi:10.1038/sj.bjp.0706997. ISSN 0007-1188. PMC 2189774 . PMID 17245371.
Salahudeen, Mohammed Saji; Nishtala, Prasad S. (2017-02). "An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice". Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society. 25 (2): 165–175. doi:10.1016/j.jsps.2016.07.002. ISSN 1319-0164. PMC 5355565 . PMID 28344466.
Lambert, Dg (2004-12). "Drugs and receptors". Continuing Education in Anaesthesia Critical Care & Pain (dalam bahasa Inggris). 4 (6): 181–184. doi:10.1093/bjaceaccp/mkh049.
Vanderheyden, P. M.; Fierens, F. L.; De Backer, J. P.; Fraeyman, N.; Vauquelin, G. (1999-02). "Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors". British Journal of Pharmacology. 126 (4): 1057–1065. doi:10.1038/sj.bjp.0702398. ISSN 0007-1188. PMC 1571230 . PMID 10193788.
Sica, D. A. (2001-01). "Clinical pharmacology of the angiotensin receptor antagonists". Journal of Clinical Hypertension (Greenwich, Conn.). 3 (1): 45–49. doi:10.1111/j.1524-6175.2001.00832.x. ISSN 1524-6175.
Neubig RR, Spedding M, Kenakin T, Christopoulos A (December 2003). "International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology" (PDF). Pharmacological Reviews. 55 (4): 597–606. doi:10.1124/pr.55.4.4. PMID 14657418.
Vauquelin, G.; Van Liefde, I.; Birzbier, B. B.; Vanderheyden, P. M. L. (2002-08). "New insights in insurmountable antagonism". Fundamental & Clinical Pharmacology. 16 (4): 263–272. doi:10.1046/j.1472-8206.2002.00095.x. ISSN 0767-3981. PMID 12570014.
Stephenson RP (February 1997). "A modification of receptor theory. 1956". British Journal of Pharmacology. 120 (4 Suppl): 106–20; discussion 103–5. doi:10.1111/j.1476-5381.1997.tb06784.x. PMC 3224279 . PMID 9142399. of the original article.
Lipton SA (January 2004). "Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults". NeuroRx. 1 (1): 101–10. doi:10.1602/neurorx.1.1.101. PMC 534915 . PMID 15717010.
Parsons, Chris G.; Stöffler, Albrecht; Danysz, Wojciech (2007-11). "Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse". Neuropharmacology (dalam bahasa Inggris). 53 (6): 699–723. doi:10.1016/j.neuropharm.2007.07.013.
Frang H, Cockcroft V, Karskela T, Scheinin M, Marjamäki A (August 2001). "Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors". The Journal of Biological Chemistry. 276 (33): 31279–84. doi:10.1074/jbc.M104167200. PMID 11395517.
Vauquelin, Georges; Charlton, Steven J. (2010-10). "Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action". British Journal of Pharmacology. 161 (3): 488–508. doi:10.1111/j.1476-5381.2010.00936.x. ISSN 1476-5381. PMC 2990149 . PMID 20880390.

elsevier.com

linkinghub.elsevier.com

Lambert, Dg (2004-12). "Drugs and receptors". Continuing Education in Anaesthesia Critical Care & Pain (dalam bahasa Inggris). 4 (6): 181–184. doi:10.1093/bjaceaccp/mkh049.

etymonline.com

"antagonist | Search Online Etymology Dictionary". www.etymonline.com. Diakses tanggal 2022-02-24.

guidetopharmacology.org

Neubig RR, Spedding M, Kenakin T, Christopoulos A (December 2003). "International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology" (PDF). Pharmacological Reviews. 55 (4): 597–606. doi:10.1124/pr.55.4.4. PMID 14657418.

intechopen.com

Reyes-Alcaraz, Arfaxad; Y. Lucero Garcia-Rojas, Emilio; A. Bond, Richard; K. McConnell, Bradley (2020-12-16). Catala, Angel; Ahmad, Usama, ed. Allosteric Modulators for GPCRs as a Therapeutic Alternative with High Potential in Drug Discovery (dalam bahasa Inggris). IntechOpen. doi:10.5772/intechopen.91838. ISBN 978-1-83962-931-0.
Magoma, Gabriel (2013-01-23). El-Shemy, Hany, ed. Introduction to Biochemical Pharmacology and Drug Discovery (dalam bahasa Inggris). InTech. doi:10.5772/52014. ISBN 978-953-51-0906-8.

merckmanuals.com

"Drug–Receptor Interactions - Clinical Pharmacology". Merck Manuals Professional Edition (dalam bahasa Inggris). Diakses tanggal 2022-02-24.

msdmanuals.com

"Drug–Receptor Interactions - Clinical Pharmacology". MSD Manual Professional Edition (dalam bahasa Inggris). Diakses tanggal 2022-03-04.

nature.com

Chang, Steven D; Bruchas, Michael R (2014-01). "Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery". Neuropsychopharmacology (dalam bahasa Inggris). 39 (1): 248–249. doi:10.1038/npp.2013.205. ISSN 0893-133X. PMC 3857652 . PMID 24317323. Pemeliharaan CS1: Format PMC (link)

nih.gov

ncbi.nlm.nih.gov

Negus SS (Juni 2006). "Some implications of receptor theory for in vivo assessment of agonists, antagonists and inverse agonists". Biochemical Pharmacology. 71 (12): 1663–70. doi:10.1016/j.bcp.2005.12.038. PMC 1866283 . PMID 16460689.
Stephenson RP (February 1997). "A modification of receptor theory. 1956". British Journal of Pharmacology. 120 (4 Suppl): 106–20; discussion 103–5. doi:10.1111/j.1476-5381.1997.tb06784.x. PMC 3224279 . PMID 9142399. of the original article.
Vauquelin, G.; Van Liefde, I. (2005-02). "G protein-coupled receptors: a count of 1001 conformations". Fundamental & Clinical Pharmacology. 19 (1): 45–56. doi:10.1111/j.1472-8206.2005.00319.x. ISSN 0767-3981. PMID 15660959.
Chang, Steven D; Bruchas, Michael R (2014-01). "Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery". Neuropsychopharmacology (dalam bahasa Inggris). 39 (1): 248–249. doi:10.1038/npp.2013.205. ISSN 0893-133X. PMC 3857652 . PMID 24317323. Pemeliharaan CS1: Format PMC (link)
Berg, Kelly A; Clarke, William P (2018-10-01). "Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity". International Journal of Neuropsychopharmacology (dalam bahasa Inggris). 21 (10): 962–977. doi:10.1093/ijnp/pyy071. ISSN 1461-1457. PMC 6165953 . PMID 30085126. Pemeliharaan CS1: Format PMC (link)
Ratain, Mark J.; William K. Plunkett, Jr (2003). "Principles of Pharmacodynamics". Holland-Frei Cancer Medicine. 6th edition (dalam bahasa Inggris).
Wyllie DJ, Chen PE (March 2007). "Taking the time to study competitive antagonism". British Journal of Pharmacology. 150 (5): 541–51. doi:10.1038/sj.bjp.0706997. PMC 2189774 . PMID 17245371.
Schild HO (February 1975). "An ambiguity in receptor theory". British Journal of Pharmacology. 53 (2): 311. doi:10.1111/j.1476-5381.1975.tb07365.x. PMC 1666289 . PMID 1148491.
Wyllie, D. J. A.; Chen, P. E. (2007-03). "Taking the time to study competitive antagonism". British Journal of Pharmacology. 150 (5): 541–551. doi:10.1038/sj.bjp.0706997. ISSN 0007-1188. PMC 2189774 . PMID 17245371.
Salahudeen, Mohammed Saji; Nishtala, Prasad S. (2017-02). "An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice". Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society. 25 (2): 165–175. doi:10.1016/j.jsps.2016.07.002. ISSN 1319-0164. PMC 5355565 . PMID 28344466.
Vanderheyden, P. M.; Fierens, F. L.; De Backer, J. P.; Fraeyman, N.; Vauquelin, G. (1999-02). "Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors". British Journal of Pharmacology. 126 (4): 1057–1065. doi:10.1038/sj.bjp.0702398. ISSN 0007-1188. PMC 1571230 . PMID 10193788.
Neubig RR, Spedding M, Kenakin T, Christopoulos A (December 2003). "International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology" (PDF). Pharmacological Reviews. 55 (4): 597–606. doi:10.1124/pr.55.4.4. PMID 14657418.
Vauquelin, G.; Van Liefde, I.; Birzbier, B. B.; Vanderheyden, P. M. L. (2002-08). "New insights in insurmountable antagonism". Fundamental & Clinical Pharmacology. 16 (4): 263–272. doi:10.1046/j.1472-8206.2002.00095.x. ISSN 0767-3981. PMID 12570014.
Stephenson RP (February 1997). "A modification of receptor theory. 1956". British Journal of Pharmacology. 120 (4 Suppl): 106–20; discussion 103–5. doi:10.1111/j.1476-5381.1997.tb06784.x. PMC 3224279 . PMID 9142399. of the original article.
Lipton SA (January 2004). "Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults". NeuroRx. 1 (1): 101–10. doi:10.1602/neurorx.1.1.101. PMC 534915 . PMID 15717010.
Frang H, Cockcroft V, Karskela T, Scheinin M, Marjamäki A (August 2001). "Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors". The Journal of Biological Chemistry. 276 (33): 31279–84. doi:10.1074/jbc.M104167200. PMID 11395517.
Vauquelin, Georges; Charlton, Steven J. (2010-10). "Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action". British Journal of Pharmacology. 161 (3): 488–508. doi:10.1111/j.1476-5381.2010.00936.x. ISSN 1476-5381. PMC 2990149 . PMID 20880390.

pubmed.ncbi.nlm.nih.gov

Vauquelin, G.; Van Liefde, I. (2005-02). "G protein-coupled receptors: a count of 1001 conformations". Fundamental & Clinical Pharmacology. 19 (1): 45–56. doi:10.1111/j.1472-8206.2005.00319.x. ISSN 0767-3981. PMID 15660959.
Wyllie, D. J. A.; Chen, P. E. (2007-03). "Taking the time to study competitive antagonism". British Journal of Pharmacology. 150 (5): 541–551. doi:10.1038/sj.bjp.0706997. ISSN 0007-1188. PMC 2189774 . PMID 17245371.
Salahudeen, Mohammed Saji; Nishtala, Prasad S. (2017-02). "An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice". Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society. 25 (2): 165–175. doi:10.1016/j.jsps.2016.07.002. ISSN 1319-0164. PMC 5355565 . PMID 28344466.
Vanderheyden, P. M.; Fierens, F. L.; De Backer, J. P.; Fraeyman, N.; Vauquelin, G. (1999-02). "Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors". British Journal of Pharmacology. 126 (4): 1057–1065. doi:10.1038/sj.bjp.0702398. ISSN 0007-1188. PMC 1571230 . PMID 10193788.
Sica, D. A. (2001-01). "Clinical pharmacology of the angiotensin receptor antagonists". Journal of Clinical Hypertension (Greenwich, Conn.). 3 (1): 45–49. doi:10.1111/j.1524-6175.2001.00832.x. ISSN 1524-6175.
Vauquelin, G.; Van Liefde, I.; Birzbier, B. B.; Vanderheyden, P. M. L. (2002-08). "New insights in insurmountable antagonism". Fundamental & Clinical Pharmacology. 16 (4): 263–272. doi:10.1046/j.1472-8206.2002.00095.x. ISSN 0767-3981. PMID 12570014.
Vauquelin, Georges; Charlton, Steven J. (2010-10). "Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action". British Journal of Pharmacology. 161 (3): 488–508. doi:10.1111/j.1476-5381.2010.00936.x. ISSN 1476-5381. PMC 2990149 . PMID 20880390.

oup.com

academic.oup.com

Ariëns, E J; Simonis, A M (2011-04-12). "A molecular basis for drug action.: The interaction of one or more drugs with different receptors". Journal of Pharmacy and Pharmacology (dalam bahasa Inggris). 16 (5): 289–312. doi:10.1111/j.2042-7158.1964.tb07461.x. ISSN 2042-7158.
Berg, Kelly A; Clarke, William P (2018-10-01). "Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity". International Journal of Neuropsychopharmacology (dalam bahasa Inggris). 21 (10): 962–977. doi:10.1093/ijnp/pyy071. ISSN 1461-1457. PMC 6165953 . PMID 30085126. Pemeliharaan CS1: Format PMC (link)

oxfordlearnersdictionaries.com

Dictionaries, Oxford Learner's. "Antagonist". Oxford Learner's Dictionaries. Diakses tanggal 2022-03-04.

psu.edu

citeseerx.ist.psu.edu

Christopoulos, Arthur (2002-03). "Allosteric binding sites on cell-surface receptors: novel targets for drug discovery". Nature Reviews Drug Discovery (dalam bahasa Inggris). 1 (3): 198–210.p1. doi:10.1038/nrd746. ISSN 1474-1776.

researchgate.net

Colquhoun, David (2007-12). "Why the Schild method is better than Schild realised". Trends in Pharmacological Sciences (dalam bahasa Inggris). 28 (12): 608–614. doi:10.1016/j.tips.2007.09.011.
Parsons, Chris G.; Stöffler, Albrecht; Danysz, Wojciech (2007-11). "Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse". Neuropharmacology (dalam bahasa Inggris). 53 (6): 699–723. doi:10.1016/j.neuropharm.2007.07.013.

sagepub.com

journals.sagepub.com

Buker, Shane M.; Boriack-Sjodin, P. Ann; Copeland, Robert A. (2019-06). "Enzyme–Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality". SLAS DISCOVERY: Advancing the Science of Drug Discovery (dalam bahasa Inggris). 24 (5): 515–522. doi:10.1177/2472555219829898. ISSN 2472-5552.

worldcat.org

Katzung, Bertram G. (1989). Farmakologi dasar dan klinik = basic and clinical pharmacology. EGC. ISBN 979-448-088-6. OCLC 850127940.
Stringer, Janet L. (2011). Basic concepts in pharmacology : what you need to know for each drug class (edisi ke-4th ed). New York: McGraw-Hill. ISBN 978-0-07-176942-6. OCLC 715319038. Pemeliharaan CS1: Teks tambahan (link)
Christopoulos, Arthur (2002-03). "Allosteric binding sites on cell-surface receptors: novel targets for drug discovery". Nature Reviews Drug Discovery (dalam bahasa Inggris). 1 (3): 198–210.p1. doi:10.1038/nrd746. ISSN 1474-1776.
Ariëns, E J; Simonis, A M (2011-04-12). "A molecular basis for drug action.: The interaction of one or more drugs with different receptors". Journal of Pharmacy and Pharmacology (dalam bahasa Inggris). 16 (5): 289–312. doi:10.1111/j.2042-7158.1964.tb07461.x. ISSN 2042-7158.
Vauquelin, G.; Van Liefde, I. (2005-02). "G protein-coupled receptors: a count of 1001 conformations". Fundamental & Clinical Pharmacology. 19 (1): 45–56. doi:10.1111/j.1472-8206.2005.00319.x. ISSN 0767-3981. PMID 15660959.
Chang, Steven D; Bruchas, Michael R (2014-01). "Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery". Neuropsychopharmacology (dalam bahasa Inggris). 39 (1): 248–249. doi:10.1038/npp.2013.205. ISSN 0893-133X. PMC 3857652 . PMID 24317323. Pemeliharaan CS1: Format PMC (link)
Berg, Kelly A; Clarke, William P (2018-10-01). "Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity". International Journal of Neuropsychopharmacology (dalam bahasa Inggris). 21 (10): 962–977. doi:10.1093/ijnp/pyy071. ISSN 1461-1457. PMC 6165953 . PMID 30085126. Pemeliharaan CS1: Format PMC (link)
Buker, Shane M.; Boriack-Sjodin, P. Ann; Copeland, Robert A. (2019-06). "Enzyme–Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality". SLAS DISCOVERY: Advancing the Science of Drug Discovery (dalam bahasa Inggris). 24 (5): 515–522. doi:10.1177/2472555219829898. ISSN 2472-5552.
Wyllie, D. J. A.; Chen, P. E. (2007-03). "Taking the time to study competitive antagonism". British Journal of Pharmacology. 150 (5): 541–551. doi:10.1038/sj.bjp.0706997. ISSN 0007-1188. PMC 2189774 . PMID 17245371.
Salahudeen, Mohammed Saji; Nishtala, Prasad S. (2017-02). "An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice". Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society. 25 (2): 165–175. doi:10.1016/j.jsps.2016.07.002. ISSN 1319-0164. PMC 5355565 . PMID 28344466.
Vanderheyden, P. M.; Fierens, F. L.; De Backer, J. P.; Fraeyman, N.; Vauquelin, G. (1999-02). "Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors". British Journal of Pharmacology. 126 (4): 1057–1065. doi:10.1038/sj.bjp.0702398. ISSN 0007-1188. PMC 1571230 . PMID 10193788.
Sica, D. A. (2001-01). "Clinical pharmacology of the angiotensin receptor antagonists". Journal of Clinical Hypertension (Greenwich, Conn.). 3 (1): 45–49. doi:10.1111/j.1524-6175.2001.00832.x. ISSN 1524-6175.
Vauquelin, G.; Van Liefde, I.; Birzbier, B. B.; Vanderheyden, P. M. L. (2002-08). "New insights in insurmountable antagonism". Fundamental & Clinical Pharmacology. 16 (4): 263–272. doi:10.1046/j.1472-8206.2002.00095.x. ISSN 0767-3981. PMID 12570014.
Vauquelin, Georges; Charlton, Steven J. (2010-10). "Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action". British Journal of Pharmacology. 161 (3): 488–508. doi:10.1111/j.1476-5381.2010.00936.x. ISSN 1476-5381. PMC 2990149 . PMID 20880390.